Research Progress on the Relationship between Mitochondrial Dysfunction and Post-stroke Depression

doi:10.12114/j.issn.1007-9572.2021.02.099

Abstract

Abstract:

Post-stroke depression (PSD) is one of the most common emotional disorders that occurs after cerebrovascular diseases, with core symptoms mainly including low mood, loss of interest, and behavioral inhibition. A large amount of evidence indicates that mitochondrial dysfunction is one of the important pathophysiological factors in the occurrence and development of depression, so we put forward the hypothesis that mitochondrial dysfunction may be one of the pathogeneses of PSD. The article reviewed the relationship between mitochondrial dysfunction and PSD from the aspects of mitochondrial energy metabolism disorder, oxidative stress, deletions, damage or mutation of mitochondrial DNA, and apoptosis, so as to clarify the specific role of mitochondrial dysfunction in the pathogenesis of PSD and provide a new theoretical basis for the development of targeted antidepressants in the future.

Key words: Stroke, Depression, Post-stroke depression, Mitochondrial dysfunction, Oxidative stress, Energy metabolism, Apoptosis

摘要：

脑卒中后抑郁（PSD）是发生于脑血管疾病后常见的一种情绪、情感障碍，核心症状主要表现为心境低落、兴趣消退、行为抑制等。大量证据表明线粒体功能障碍是抑郁症发生、发展的重要病理生理因素之一，遂提出线粒体功能障碍有可能是PSD的发病机制之一这一假说。本文将从线粒体能量代谢障碍、氧化应激、线粒体DNA缺失、损伤或突变、细胞凋亡等方面综述线粒体功能障碍与PSD的关系，为明确线粒体功能障碍在PSD发病过程中的具体作用，为今后开发靶向抗抑郁药物提供新的理论依据。

关键词: 卒中, 抑郁, 脑卒中后抑郁, 线粒体功能障碍, 氧化应激, 能量代谢, 细胞凋亡

Zhimin DING,Kaiqi SU,Jing GAO, et al. Research Progress on the Relationship between Mitochondrial Dysfunction and Post-stroke Depression[J]. Chinese General Practice, 2022, 25(12): 1528-1532. DOI: 10.12114/j.issn.1007-9572.2021.02.099.
丁志敏,苏凯奇,高静等. 线粒体功能障碍与脑卒中后抑郁的关系研究进展[J]. 中国全科医学, 2022, 25(12): 1528-1532. DOI: 10.12114/j.issn.1007-9572.2021.02.099.

References 45

[1]	CAI W, MUELLER C, LI Y J，et al. Post stroke depression and risk of stroke recurrence and mortality：a systematic review and meta-analysis[J]. Ageing Res Rev，2019，50：102-109. DOI：10.1016/j.arr.2019.01.013.
[2]	VILLA R F, FERRARI F, MORETTI A. Post-stroke depression：Mechanisms and pharmacological treatment[J]. Pharmacol Ther，2018，184：131-144. DOI：10.1016/j.pharmthera.2017.11.005.
[3]	DAS J, G K R. Post stroke depression：The sequelae of cerebral stroke[J]. Neurosci Biobehav Rev，2018，90：104-114. DOI：10.1016/j.neubiorev.2018.04.005.
[4]	ANDRABI S S, PARVEZ S, TABASSUM H. Ischemic stroke and mitochondria：mechanisms and targets[J]. Protoplasma，2020，257(2)：335-343. DOI：10.1007/s00709-019-01439-2.
[5]	DE DIEGO-ADELIÑO J, PORTELLA M J, GÓMEZ-ANSÓN B，et al. Hippocampal abnormalities of glutamate/glutamine，N-acetylaspartate and choline in patients with depression are related to past illness burden[J]. J Psychiatry Neurosci，2013，38(2)：107-116. DOI：10.1503/jpn.110185.
[6]	JI X W, WU C L, WANG X C，et al. Monoamine neurotransmitters and fibroblast growth factor-2 in the brains of rats with post-stroke depression[J]. Exp Ther Med，2014，8(1)：159-164. DOI：10.3892/etm.2014.1674.
[7]	HAMA S, MURAKAMI T, YAMASHITA H，et al. Neuroanatomic pathways associated with monoaminergic dysregulation after stroke[J]. Int J Geriatr Psychiatry，2017，32(6)：633-642. DOI：10.1002/gps.4503.
[8]	ZHOU S J, LIU S, LIU X Q，et al. Selective serotonin reuptake inhibitors for functional independence and depression prevention in early stage of post-stroke：a meta-analysis[J]. Medicine （Baltimore），2020，99(6)：e19062. DOI：10.1097/MD.0000000000019062.
[9]	MAYEVSKY A, KUTAI-ASIS H, TOLMASOV M. Mitochondrial function and brain Metabolic Score （BMS） in ischemic Stroke：Evaluation of "neuroprotectants" safety and efficacy[J]. Mitochondrion，2020，50：170-194. DOI：10.1016/j.mito.2019.11.005.
[10]	周群，李月峰，朱彦. PET-CT检测首发单相重度抑郁症患者神经环路的葡萄糖代谢水平[J]. 江苏大学学报：医学版，2015，25(4)：335-338. DOI：10.13312/j.issn.1671-7783.y150037.
[11]	CAO X, LI L P, WANG Q，et al. Astrocyte-derived ATP modulates depressive-like behaviors[J]. Nat Med，2013，19(6)：773-777. DOI：10.1038/nm.3162.
[12]	FERRARI F, VILLA R F. The neurobiology of depression：an integrated overview from biological theories to clinical evidence[J]. Mol Neurobiol，2017，54(7)：4847-4865. DOI：10.1007/s12035-016-0032-y.
[13]	杨若聪，田朋朋，吴传鸿，等. 益气解毒方基于线粒体保护的抗缺血性脑卒中研究[J]. 世界中医药，2017，12(11)：2731-2735. DOI：10.3969/j.issn.1673-7202.2017.11.042.
[14]	何喜美，向华. 艾地苯醌对缺血性脑卒中后抑郁症患者血清炎性因子和生活质量的影响[J]. 解放军医药杂志，2018，30(6)：96-99. DOI：10.3969/j.issn.2095-140X.2018.06.025.
[15]	ALLEN J, ROMAY-TALLON R, BRYMER K J，et al. Mitochondria and mood：mitochondrial dysfunction as a key player in the manifestation of depression[J]. Front Neurosci，2018，12：386. DOI：10.3389/fnins.2018.00386.
[16]	韩胜斌，郭蓉娟，高维，等. 醒脾解郁法对抑郁大鼠肝脏能量代谢的调控机制研究[J]. 环球中医药，2018，11(12)：1862-1866. DOI：10.3969/j.issn.1674-1749.2018.12.002.
[17]	EMMERZAAL T L, PRESTON G, GEENEN B，et al. Impaired mitochondrial complex I function as a candidate driver in the biological stress response and a concomitant stress-induced brain metabolic reprogramming in male mice[J]. Transl Psychiatry，2020，10(1)：176. DOI：10.1038/s41398-020-0858-y.
[18]	AGUIAR A S Jr, STRAGIER E, DA LUZ SCHEFFER D，et al. Effects of exercise on mitochondrial function，neuroplasticity and anxio-depressive behavior of mice[J]. Neuroscience，2014，271：56-63. DOI：10.1016/j.neuroscience.2014.04.027.
[19]	NAGY E E, FRIGY A, SZÁSZ J A，et al. Neuroinflammation and microglia/macrophage phenotype modulate the molecular background of post-stroke depression：a literature review[J]. Exp Ther Med，2020，20(3)：2510-2523. DOI：10.3892/etm.2020.8933.
[20]	WIJERATNE T, SALES C. Understanding why post-stroke depression may be the norm rather than the exception：the anatomical and neuroinflammatory correlates of post-stroke depression[J]. J Clin Med，2021，10(8)：1674. DOI：10.3390/jcm10081674.
[21]	YANG L L, ZHANG Z J, SUN D M，et al. The serum interleukin-18 is a potential marker for development of post-stroke depression[J]. Neurol Res，2010，32(4)：340-346. DOI：10.1179/016164110X12656393665080.
[22]	WU D, ZHANG G C, ZHAO C Y，et al. Interleukin-18 from neurons and microglia mediates depressive behaviors in mice with post-stroke depression[J]. Brain Behav Immun，2020，88：411-420. DOI：10.1016/j.bbi.2020.04.004.
[23]	PIZZINO G, IRRERA N, CUCINOTTA M，et al. Oxidative stress：harms and benefits for human health[J]. Oxid Med Cell Longev，2017，2017：8416763. DOI：10.1155/2017/8416763.
[24]	PETSCHNER P, GONDA X, BAKSA D，et al. Genes linking mitochondrial function，cognitive impairment and depression are associated with endophenotypes serving precision medicine[J]. Neuroscience，2018，370：207-217. DOI：10.1016/j.neuroscience.2017.09.049.
[25]	MCGARRY T, BINIECKA M, VEALE D J，et al. Hypoxia，oxidative stress and inflammation[J]. Free Radic Biol Med，2018，125：15-24. DOI：10.1016/j.freeradbiomed.2018.03.042.
[26]	CADENAS S. Mitochondrial uncoupling，ROS generation and cardioprotection[J]. Biochim Biophys Acta Bioenerg，2018，1859(9)：940-950. DOI：10.1016/j.bbabio.2018.05.019.
[27]	DU R H, WU F F, LU M，et al. Uncoupling protein 2 modulation of the NLRP3 inflammasome in astrocytes and its implications in depression[J]. Redox Biol，2016，9：178-187. DOI：10.1016/j.redox.2016.08.006.
[28]	BAI B C, YANG Y Y, WANG Q，et al. NLRP3 inflammasome in endothelial dysfunction[J]. Cell Death Dis，2020，11(9)：776. DOI：10.1038/s41419-020-02985-x.
[29]	YAN C J, DUANMU X Y, ZENG L，et al. Mitochondrial DNA：distribution，mutations，and elimination[J]. Cells，2019，8(4)：379. DOI：10.3390/cells8040379.
[30]	WEST A P, SHADEL G S. Mitochondrial DNA in innate immune responses and inflammatory pathology[J]. Nat Rev Immunol，2017，17(6)：363-375. DOI：10.1038/nri.2017.21.
[31]	NISSANKA N, MORAES C T. Mitochondrial DNA damage and reactive oxygen species in neurodegenerative disease[J]. FEBS Lett，2018，592(5)：728-742. DOI：10.1002/1873-3468.12956.
[32]	YANG Y, KARAKHANOVA S, HARTWIG W，et al. Mitochondria and mitochondrial ROS in cancer：novel targets for anticancer therapy[J]. J Cell Physiol，2016，231(12)：2570-2581. DOI：10.1002/jcp.25349.
[33]	LIU Q, ZHANG D, HU D，et al. The role of mitochondria in NLRP3 inflammasome activation[J]. Mol Immunol，2018，103：115-124. DOI：10.1016/j.molimm.2018.09.010.
[34]	CZARNY P, WIGNER P, STRYCHARZ J，et al. Mitochondrial DNA copy number，damage，repair and degradation in depressive disorder[J]. World J Biol Psychiatry，2020，21(2)：91-101. DOI：10.1080/15622975.2019.1588993.
[35]	KATO T. Neurobiological basis of bipolar disorder：Mitochondrial dysfunction hypothesis and beyond[J]. Schizophr Res，2017，187：62-66. DOI：10.1016/j.schres.2016.10.037.
[36]	ILUT S, STAN A, BLESNEAG A，et al. Factors that influence the severity of post-stroke depression[J]. J Med Life，2017，10(3)：167-171.
[37]	TU J, WANG L X, WEN H F，et al. The association of different types of cerebral infarction with post-stroke depression and cognitive impairment[J]. Medicine （Baltimore），2018，97(23)：e10919. DOI：10.1097/MD.0000000000010919.
[38]	ZHANG T, JING X, ZHAO X Q，et al. A prospective cohort study of lesion location and its relation to post-stroke depression among Chinese patients[J]. J Affect Disord，2012，136(1/2)：e83-87. DOI：10.1016/j.jad.2011.06.014.
[39]	XU X B, LAI Y Y, HUA Z C. Apoptosis and apoptotic body：disease message and therapeutic target potentials[J]. Biosci Rep，2019，39(1). DOI：10.1042/bsr20180992.
[40]	BOCK F J, TAIT S W G. Mitochondria as multifaceted regulators of cell death[J]. Nat Rev Mol Cell Biol，2020，21(2)：85-100. DOI：10.1038/s41580-019-0173-8.
[41]	陈东风，房殿春. 线粒体膜通透性转换孔与细胞凋亡[J]. 第三军医大学学报，2004，26(17)：1598-1600.
[42]	CHEN Q, GONG B, ALMASAN A. Distinct stages of cytochrome c release from mitochondria：evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis[J]. Cell Death Differ，2000，7(2)：227-233. DOI：10.1038/sj.cdd.4400629.
[43]	GRIFFITHS E J. Mitochondria and heart disease[J]. Adv Exp Med Biol，2012，942：249-267. DOI：10.1007/978-94-007-2869-1_11.
[44]	史华伟，郭蓉娟，赵振武，等. 醒脾解郁方对抑郁大鼠行为学及海马与骨骼肌线粒体超微结构的影响[J]. 北京中医药大学学报，2017，40(4)：284-289.
[45]	YANG J L, MUKDA S, CHEN S D. Diverse roles of mitochondria in ischemic stroke[J]. Redox Biol，2018，16：263-275. DOI：10.1016/j.redox.2018.03.002.